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Abstract 
Squamous cell carcinoma of the scrotum is
a tumor that is of interest for clinical and his-
torical reasons. It was the first cancer linked to
occupational exposure when, in 1775, Perivall
Pott    described  it  in  chimney  sweeps  in
England. Other occupations that had a prepon-
derance  of  the  disease  included  people  who
worked  with  the  distillates  of  coal  and  men
exposed to mineral oil. Currently, the disease
is  very  rare  and  most  cases  are  thought  to
result from poor hygiene and chronic irrita-
tion. Surgery with a negative resection margin
offers the best hope of cure as adjunctive ther-
apy has not proved useful. Prognosis correlates
with the  extent of nodal involvement. 
Introduction
The scrotum is a seven-layer pouch which
covers the testes, testicular adnexae, and dis-
tal spermatic cord. These layers are the epider-
mis, dermis, tunica dartos, the three layers of
Colles’ fascia and the parietal layer of the tuni-
ca vaginalis,
1 The scrotal lymphatics drain into
the corresponding superficial inguinal lymph
nodes. Anastomoses to the lymphatics of the
contralateral network across the median raphe
occur. Testicular lymphatics drain to the para-
aortic nodes. 
Tumors have been reported to arise out of
virtually any of the components of the scrotal
wall.
2Both benign and malignant tumors of the
scrotum are rare.
1 Squamous cell carcinoma of
the scrotum is now very rare; the incidence
has been reported to be less than 10 cases per
year in the United States.
2 Squamous cell car-
cinoma is the most common malignant tumor
of the scrotum; however, rare cases of basal
cell carcinoma, melanoma, Paget’s disease and
sarcoma  have  been  reported.
3 Secondary
tumors of the scrotum can occur; for instance,
carcinoid tumor of the small bowel can metas-
tasize  to  the  scrotum  simulating  a  primary
scrotal tumor.
1
Squamous cell carcinoma of the scrotum is
a tumor that is of interest for clinical and his-
torical reasons. It has been identified as a sen-
tinel health event (occupational) [(SHE(0)].
4
Synonyms  include  epidermoid  carcinoma  of
the scrotum, chimney sweepers cancer, mule-
spinners cancer and epithelioma of the scro-
tum.  It  is  customary  to  give  priority  for  the
description  of  the  disease  to  Bassius  who
described it in 1731, but it was Percivall Pott
who in 1775 described its occurrence in chim-
ney sweeps in Pott’s Chirurgical Observations,
thereby making him the first to attribute an
occupational cause to the disease. This also
established  scrotal  cancer  as  the  first
described  occupational  cancer.
1,2,5 Squamous
cell carcinoma of the scrotum has historically
been associated with exposure to occupational
(industrial)  and  non-occupational  (environ-
mental)  carcinogens.  From  the  eighteenth
century, there have been at least three broad
occupational groups with a preponderance of
the disease: chimney sweeps, people who work
with the distillates of coal, and men exposed to
mineral oil. The common hazard in these occu-
pations arises from polycyclic aromatic hydro-
carbons  in  soots,  tars  and  mineral  oils.
6 In
these industries, improved technology or the
decline of the industry have led to less men
being  affected.  Chimney  sweep  cancer  was
commoner in England, as cases were virtually
unknown in other parts of Europe or America;
attention  to  personal  hygiene  had  for  long
been  the  practice  among  the  continental
sweeps. The introduction of protective clothing
at  work  and  improved  personal  hygiene
reduced the incidence of chimney sweep can-
cer in England.
The first public notice that the distillation of
coal might induce cancer of the scrotum was
given by Von Volkman at the Third Surgical
Congress in Berlin in 1873. Tar from gas works
blast furnaces, and coke ovens was used wide-
ly from the end of the nineteenth century, both
in the original state and for the distillation of a
series  of  hydrocarbons  which  included  cre-
osote, anthracene and naphthalene. The etiol-
ogy of the disease was unclear from the time of
Pott until 1922, when Passey gave experimen-
tal evidence of the presence of weak carcino-
gens in soot, as the theory of chronic irritation
popular at the time did not fully answer all the
questions raised. Men exposed to mineral oil
included  shale  oil  workers  and  engineering
workers exposed to cutting oils. Unrefined or
mildly  refined  mineral  oils  have  substantial
levels of polycyclic aromatic hydrocarbons and
their use in industries such as printing and
metalworking in the past has led to skin can-
cers.
5 The hazard has remained but newer cir-
cumstances may now be involved. Engine oils
have elevated polycyclic aromatic hydrocarbon
content with use; prolonged and repeated con-
tact with used engine oil can cause skin and
scrotal cancer. Car mechanics are at potential
risk from used engine oils.
7 Best occupational
health  practices  are  invaluable  to  minimize
exposure at the work place. The establishment
of the concept of latent period in tumor induc-
tion in the last century helped shed light on the
observation by several writers that the scrotal
lesion appeared many years after the man had
left the job associated with squamous cell can-
cer or when he was  in another trade altogeth-
er.  In  this  respect,  Henry  Earle  and  Curling
noted the disease appearing after intervals of
15 years and 19 years, respectively.
5 Other non-
occupational  factors  that  may  be  associated
with the disease include prior history of can-
cer,  PUVA  (psoralen-ultraviolet  light)  treat-
ments,  radiotherapy,  poor  personal  hygiene
and treatment with arsenical compounds.
3,5,8,9
Case reports exist which correlated squamous
cell  carcinoma  of  the  scrotum  with  human
papilloma viruses, mainly oncogenic types 16
and /or 18 or 6/11
8,10,11 but a direct causal rela-
tionship has not been established. Squamous
cell carcinoma of the male genitalia may be
multifocal,
12 especially when oncogenic human
papillomavirus types are present.
10
Patients frequently delayed seeking medical
help,
5 mainly due to embarrassment, ignorance
or both; that the initial lesion is usually slowly
growing and painless may also be contributory.
In a case series of 9 patients, M
c Donald report-
ed that the interval between patient awareness
of the lesion to diagnosis averaged 3.3 years.
13
In a case series of 19 patients seen between
1948 and 1971, Ray and Whitmore found the
interval before presentation was 26 months.
9
However,  in  earlier  reviews  the  interval
between onset of symptoms and treatment was
reported  to  have  been  about  10-12  months.
9
This may suggest that as the disease became
less  common,  the  interval  between  onset  of
symptoms and presentation increased.
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The patients afflicted with chimney sweeps
cancer were generally young men. Writing in
1832, Henry Earle considered that the majority
of cases were in patients between the ages of
30  and  40.  Green  analyzed  36  cases  pooled
from the eighteenth and nineteenth century
literature and found the mean age of presenta-
tion was 37.7 years.
5 However in the series by
Ray and Whitmore, which involved cases seen
between 1948 and 1971, the average age was





Squamous  cell  carcinoma  of  the  scrotum
frequently present as a solitary wart or nodule
on  the  scrotum.  There  seems    to  be  no
predilection for any side, if patients with occu-
pational  cancer  are  excluded.
9 Superficial
ulceration may follow increase in size or the
effect  of  scratching  at  the  lesion.  Ulcerated
lesions may have a sero-sanguinous discharge
that may become profuse and foul-smelling if
infected. If an ulcer is present, it is a malig-
nant squamous ulcer and would have features
expected of such. There may be ipsilateral or
bilateral  inguinal  lymph  node  enlargement
which may be inflammatory or neoplastic or
both.
9 In some cases, the growth may become
large  and  grotesque.  Pain  is  usually  absent
until  late  stages  of  the  disease.  Azike,
Chukwujama and Oguike reported on a recent
case of squamous cell carcinoma of the scro-
tum with penile and testicular involvement in




The lesion tends to remain localized to the
scrotal  wall,  may  occasionally  involves  the
adjacent perineal skin but rarely involve the
scrotal  contents  or  penis;  distant  spread  is
rare.
9 The pubic bone is occasionally involved
by  direct  extension.
14,15 In  the  series  of  141
cases,  Southan  and  Wilson  found  testicular
involvement  in  6  and  penile  in  3  cases.
16
Spread is to the inquinal which may be unilat-
eral, bilateral or crossed; iliac nodes, the para
aortic  nodes,  and  may  reach  the  lungs.
Metastatic involvement has been reported as
early as four months or as late as ten years.
17
The iliac nodes may be involved when there is
no recognized inguinal involvement.
9
Primary tumors in other sites  
Dean noted the high incidence of multiple
primary tumors in patients with scrotal cancer.
In his series, 8 of 27 patients had other pri-
mary  tumor.
17 In  the  series  by  Ray  and
Whitmore,
8 9 of 19 patients had another pri-
mary  tumor.
9 Weinstein,  Howe  and  Burnett
found that 8 out of the 19 cases had prior his-
tory of cancer.
4 Lione and Denholm described a
patient who died of stomach cancer two years
after treatment for scrotal carcinoma.
9
Diagnosis 
The diagnosis is suggested clinically and is
confirmed by wedge biopsy of the edge of the
scrotal lesion. Refractory scrotal inflammatory
lesions should be biopsied to rule out squa-
mous  cell  carcinoma.  General  investigations
include  full  blood  count,  serum  electrolytes
urea  creatinine  estimation,  liver  function
tests,  urinalysis,  urine  culture  if  indicated,
wound swab culture and sensitivity if ulcera-
tion is present. There is need for extensive
evaluation  with  appropriate  investigative
modalities  to  exclude  associated  internal
malignancy.  Staging  investigations  include
abdomino-pelviscrotal ultrasound, MRI of the
scrotum, and chest CT.
Staging 




A1 Disease localized to the scrotum 
A2 Locally  extensive  disease  involving 
adjacent  structures  (penis,  perineum, 
testis  and/or  cord  structures,  pubic
bone) by continuity but without evident
metastasis. 
Stage B
Regional* metastasis, resectable 
Stage C
Regional metastasis, non-resectable 
Stage D
Distant metastasis (beyond regional nodes) 
*Inguinal or ilioinguinal  
Treatment 
The established treatment for squamous cell
carcinoma  of  the  scrotum  is  wide  excision
with a 2-3 cm margin. Surrounding subcuta-
neous tissue should be excised with the pri-
mary tumor. Resection of the scrotal contents
is  rarely  necessary  for  tumor  control  unless
involved by tumor.
3,9 Intra-operative frozen sec-
tions may help to confirm a disease free mar-
gin. Primary scrotal closure is usually possible,
but may be a challenge after large tumor resec-
tion. Many investigators have reported various
methods to cover a healthy testis when primary
closure is not feasible. These include immedi-
ate  use  of  local  thigh  flaps,
18 myocutaneous
gracilis  or  adductor  minimus  myocutaneaus
flaps, and heterologous fascia grafts.
19-21
Other investigators place the exposed testis in
the subcutaneous tissue of the thigh or femoral
region or do ipsilateral orchidectomy.
15,22,23 Others
do contralateral testicular transposition follow-
ing a hemiscrotectomy.
24 Local recurrence may
occasionally occur and may be due to insuffi-
cient tumor resection or may represent new
lesions.
9,24 Adjunctive treatment like radiother-
apy or chemotherapy or both has not proved
useful, and only palliation is usually feasible
for  late  stage  disease.  A  multidisciplinary
approach may be necessary to fully address all
aspects of patient management.
Treatment of the regional lymph
nodes  
Briefly, the optimal management of patients
with squamous cell carcinoma of the scrotum
with clinically negative inguinal node is contro-
versial and involves a decision as to whether a
prophylactic  or  therapeutic  node  dissection
should be performed. Some authors
15,25 propose
bilateral  radical  groin  dissection  to  remove
micrometastasis; the rationale of the contralat-
eral groin dissection being the free communi-
cation between the lymphatics of the two sides
of the scrotum. Dean emphasized that only 50%
of patients with inquinal adenopathy actually
had  metastases, suggesting that routine dis-
section  would  be  useful  only  in  half  of  the
patients with inquinal adenopathy. He advocat-
ed  bilateral  groin  dissection  only  for  proved
metastases.
17Ray and Whitmore  based on their
experience, advocated patient follow-up at 2-3
month intervals after excision of primary lesion
and to perform an ipsilateral ilioinguinal dis-
section if there is clinical evidence of metasta-
sis proved by biopsy, and to perform an ipsilat-
eral ilioinguinal dissection if there is clinical
evidence of metastasis proved by biopsy, and to
defer contralateral ilioinguinal dissection until
there is clinical evidence of metastasis. Presti
jr. advocated observation for clinically negative
lymph nodes, but patients with clinically palpa-
ble nodes to be given antibiotics first. If the
groin nodes remain clinically palpable, ilioin-
guinal lymph node dissection is performed. But
if  it  becomes  clinically  negative  after  broad
spectrum antibiotics, limited node sampling is
performed. If positive, ilioinguinal lymph node




An important prognostic factor is the ability
to completely excise the tumor at the time of
initial surgery.
2 Prognosis correlates with the
presence or absence of nodal involvement. If
the inguinal nodes are involved the 5-year sur-
vival rate is approximately 25%. There are vir-
tually no survivors if the iliac nodes are affect-
ed.
3,9 In a review of a series of 18 patients, Ray
and Whitmore Jr found no correlation among
the patient age, duration of symptoms, size,
histological type or grade of the tumor and sur-
vival. However, they reported that patients with
high tumor burden had the worst prognosis; no
patient  with  non-resectable  metastasis  or
metastases  beyond  the  inquinal  nodes  sur-
vived.
9 Patient follow-up is for life.
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Conclusions
Squamous cell carcinoma of the scrotum is
now a rare clinical entity and it is given only
scant attention in most urological textbooks. It
is pertinent to once again remind the medical
community of the existence of this disease and
provide  a  brief  summary  of  its  history,  epi-
demiology and treatment from the literature  to
add to the resources available to the practising
urologists and oncologists. 
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